PAR
Click for more information
0.00% 23.0¢ paradigm biopharmaceuticals limited..

1% chance of approval because the drug is repurposed...?If PPS...

  1. Gvan
    1,637 Posts.
    lightbulb Created with Sketch. 2960
    clock Created with Sketch.
    18/09/21
    14:13
    Post #: 56173236
    1% chance of approval because the drug is repurposed...?

    If PPS is not approved, it will not be down to effectiveness or safety. The trials are a formality as we already have a tremendous amount of real world data and knowledge. It all depends on what big pharma's agenda is.
    PAR Price at posting: $1.82 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
BOE Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
right-arrow Created with Sketch.
NEWS Diggers & Dealers 2024: Kim Beazley ties mining and military together; highlights competition with China in Africa
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $80.45M
Open High Low Value Volume
23.0¢ 23.5¢ 23.0¢ $26.71K 116.0K

Buyers (Bids)

No. Vol. Price($)
3 52687 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 3305 3
View Market Depth
Last trade - 10.41am 06/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.